These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4383871)

  • 1. In vitro effects of some chemotherapeutic agents on mycobacteria.
    Olitzki AL; Godinger D; Israeli M; Honigman A
    Appl Microbiol; 1967 Sep; 15(5):994-1001. PubMed ID: 4383871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic studies of mycobacterial infections in mice.
    Olitzki AL; Olitzki Z; Davis CL
    Appl Microbiol; 1968 Mar; 16(3):500-5. PubMed ID: 4384964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction.
    Weisblum B; Siddhikol C; Lai CJ; Demohn V
    J Bacteriol; 1971 Jun; 106(3):835-47. PubMed ID: 4397638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifamycin resistance in mycobacteria.
    Cole ST
    Res Microbiol; 1996; 147(1-2):48-52. PubMed ID: 8761722
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of lincomycin and spectinomycin against serotypes of avian mycoplasma.
    Hamdy AH; Blanchard CJ
    Appl Microbiol; 1970 Jul; 20(1):26-30. PubMed ID: 4248002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA; Gomez Garcia AC
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The susceptibility of Mycobacterium tuberculosis and atypical mycobacteria in northern Israel.
    Cahana Z; Gabbay R; Raz R
    Drugs; 1995; 49 Suppl 2():171-2. PubMed ID: 8549291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.
    Ho YI; Chan CY; Cheng AF
    J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F; Esteban J; González-Martin J; Palacios JJ
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity against M. leprae of lincomycin and two derivatives, of amicetin, phosphonomycin and two derivatives of tetrahydronaphthylaminopropylpiperidine.
    Shepard CC; Van Landingham RM; Redus MA; Walker LL
    Int J Lepr Other Mycobact Dis; 1971; 39(3):742-4. PubMed ID: 4948222
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycobacteria and the new quinolones.
    Leysen DC; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1989 Jan; 33(1):1-5. PubMed ID: 2540705
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility Testing of Antibiotics That Degrade Faster than the Doubling Time of Slow-Growing Mycobacteria: Ertapenem Sterilizing Effect versus Mycobacterium tuberculosis.
    Srivastava S; van Rijn SP; Wessels AM; Alffenaar JW; Gumbo T
    Antimicrob Agents Chemother; 2016 May; 60(5):3193-5. PubMed ID: 26926650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of rifampin on mycobacteria.
    Lorian V; Finland M
    Appl Microbiol; 1969 Feb; 17(2):202-7. PubMed ID: 4975656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of long-chain fatty alcohols against mycobacteria.
    Mukherjee K; Tribedi P; Mukhopadhyay B; Sil AK
    FEMS Microbiol Lett; 2013 Jan; 338(2):177-83. PubMed ID: 23136919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the penicillinase-resistant penicillins and other chemotherapeutic substances on the penicillinase of the R1Rv strain of Mycobacterium tuberculosis.
    Kasik JE; Weber M; Freehill PJ
    Am Rev Respir Dis; 1967 Jan; 95(1):12-9. PubMed ID: 4959428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.